Suggested Topics within your search.
Suggested Topics within your search.
- Cancer 1
- Gynecology 1
- Obstetrics 1
- Oncology 1
- Pediatric 1
- Pediatric Hematology 1
- Pediatric hematology 1
- methods 1
-
3201
Identification of novel pQTL‐SNPs associated with lung adenocarcinoma risk: A multi‐stage study
Published 2024-09-01Get full text
Article -
3202
Pembrolizumab and Pemetrexed for Older Patients With Nonsquamous NSCLC and Programmed Cell Death-Ligand 1 Tumor Proportion Scores of Less Than 50%
Published 2025-03-01“…Eligible participants had metastatic or recurrent nonsquamous NSCLC without sensitizing EGFR or ALK alterations, were aged 75 years or above, had a programmed cell death-ligand 1 tumor proportion score of less than 50%, had not undergone systemic chemotherapy, and had an Eastern Cooperative Oncology Group performance status of 0 or 1. Patients received pemetrexed (500 mg/m2) and pembrolizumab (200 mg) on day 1 of each 21-day cycle. …”
Get full text
Article -
3203
-
3204
-
3205
NALCN expression is down-regulated and associated with immune infiltration in gastric cancer
Published 2025-02-01Get full text
Article -
3206
Clinical characteristics and outcomes of patients with chondroblastoma undergoing surgery with various adjuvant procedures: a retrospective study of 59 cases
Published 2025-01-01“…Two patients received preoperative denosumab and neither experienced local recurrence nor functional impairments. Conclusions Good oncological and functional outcomes were achieved. Age < 17 years was associated with a high risk of local recurrence after curettage (P = 0.0198). …”
Get full text
Article -
3207
-
3208
Selective utilization of medicinal polysaccharides by human gut Bacteroides and Parabacteroides species
Published 2025-01-01Get full text
Article -
3209
-
3210
Preventing sensory and motor dysfunctions in children receiving neurotoxic chemotherapy: PrepAir study - an update
Published 2025-01-01“…This would show that specific exercise therapy is more than just a lifestyle intervention, it could be a therapy option without further side- effects, changing supportive care in oncology. References Bjornard, K. L., Gilchrist, L., Inaba, H., Diouf, B., Hockenberry, M. …”
Get full text
Article -
3211
-
3212
Masquerade Syndrome of Multicentre Primary Central Nervous System Lymphoma
Published 2011-01-01Get full text
Article -
3213
Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases
Published 2016-01-01Get full text
Article -
3214
Combination Therapy of PPAR𝛾 Ligands and Inhibitors of Arachidonic Acid in Lung Cancer
Published 2008-01-01Get full text
Article -
3215
Nanomédicaments pour le traitement de maladies graves et recherches duales
Published 2024-11-01“…Nanomedicines have made significant advances in various therapeutic areas such as oncology, infectious diseases, and several neurological disorders. …”
Get full text
Article -
3216
Solitary Lytic Bone Metastasis: A Rare Presentation of Small Lymphocytic Leukemia
Published 2018-01-01Get full text
Article -
3217
Apoptotic cell death, detected ex vivo in peripheral blood lymphocytes of HIV-1 infected persons
Published 1996-01-01Get full text
Article -
3218
The Natural History and Outcomes of the Patients with Carcinosarcoma Involving Kidney and Renal Pelvis
Published 2011-01-01Get full text
Article -
3219
Pretreatment Thrombocytosis as a Prognostic Factor in Metastatic Breast Cancer
Published 2013-01-01Get full text
Article -
3220
Amebic Encephalitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy
Published 2018-01-01Get full text
Article